Oscient Pharmaceuticals (OSCI) Inactive 10-Q2003 Q2 Quarterly report

Filed: 12 Aug 03, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: acquisition, adjudicated, anniversary, applied, approximtaely, arisen, category, Chairman, Chapter, Chemistry, claim, CMC, Code, compensated, competitor, complex, compose, consideration, constitute, consulting, control, DatabaseTM, debtor, demonstrate, direct, effort, emergence, Emerging, environment, equal, exemption, externally, facilitate, failure, falling, FASB, favorable, FDA, Fiduciary, Food, formulation, fulfill, fully, furnished, heavily, herewith, hiring, increasingly, incremental, Induced, inherent, intense, investor, issuable, issuancedate, lack, legal, LLC, measure, member, ordinary, outlicense, payoff, platform, population, predict, previously, produced, ratio, reached, realize, realized, redeemed, redemption, referenced, release, reverse, settlement, shelf, skilled, Smithfield, specialty, succeed, successful, summary, superior, Tail, Task, Title, track, ultimately, unamortized, uncertain, undertook, Wind

Removed: bearing, borrowed, certifying, corporate, expansion, July, occur, periodic, Rauscher, relating, repaid, require, state, Steven, terminate, utilize

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

OSCI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as President and Chief Executive Officer of Genome Therapeutics Corp. (the “Company”) does hereby certify that to my knowledge:

the Company’s Report on Form 10-Q for the quarter ended June 28, 2003, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

the information contained in the Company’s Report on Form 10-Q for the quarter ended June 28, 2003, fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:

/s/ STEVEN M. RAUSCHER

Steven M. Rauscher

President & Chief Executive Officer

Dated: August 12, 2003

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.